Brian Goff
Director; Director, Chief Executive Officer · 4 filings · Latest: Jun 18, 2026
AGIOS PHARMACEUTICALS, INC.
Intellia Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AGIO | Brian Goff | Director, Chief Executive Officer | Apr 2, 2026 | Sale | $34.71 | 19,068 | $661.9K | 184,508 | |
AGIO | Brian Goff | Director, Chief Executive Officer | Apr 2, 2026 | Option Exercise | $0.00 | 39,028 | — | 191,104 | |
AGIO | Goff Brian | — | Apr 2, 2026 | Proposed Sale | $34.19 | 19,068 | $651.9K | — | |
AGIO | Brian Goff | Director, Chief Executive Officer | Mar 2, 2026 | Sale | $28.96 | 18,055 | $522.9K | 164,548 | |
AGIO | Brian Goff | Director, Chief Executive Officer | Mar 2, 2026 | Option Exercise | $0.00 | 39,500 | — | 170,466 | |
AGIO | Goff Brian | — | Mar 2, 2026 | Proposed Sale | $30.23 | 18,055 | $545.8K | — | |
AGIO | Goff Brian | — | Dec 30, 2025 | Proposed Sale | $27.16 | 18,703 | $508.0K | — | |
AGIO | Goff Brian | — | Aug 8, 2025 | Proposed Sale | $37.06 | 11,085 | $410.8K | — | |
AGIO | Goff Brian | — | Jun 24, 2025 | Proposed Sale | $34.41 | 18,507 | $636.8K | — | |
AGIO | Goff Brian | — | Mar 3, 2025 | Proposed Sale | $35.54 | 12,947 | $460.1K | — |